Document Detail


alpha-Hydroxy acid-based cosmetic procedures. Guidelines for patient management.
MedLine Citation:
PMID:  11702315     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
alpha-Hydroxy acid (AHA) peels and home regimens have recently been recognized as important adjunctive therapy in a variety of conditions including photodamage, actinic damage, melasma, hyperpigmentation disorders, acne, and rosacea. Overall in our experience and in the literature, AHAs have a proven level of safety and efficacy in a variety of skin types. Although their exact mechanism of action is unknown, it has been demonstrated that AHAs improve these disorders by thinning the stratum corneum, promoting epidermolysis, dispersing basal layer melanin, and increasing collagen synthesis within the dermis. In patients with photodamage, AHA peels and topical products are often combined with retinoids and other antioxidants for maximum benefit. Similarly, synergistic effects of fluorouracil and glycolic acid are observed in the treatment of diffuse actinic keratoses. For patients with melasma, AHA peels and combination products containing bleaching agents such as hydroquinone, kojic acid, and glycolic acid seem to have increased efficacy. Acne and rosacea patients can see improved results when standard regimens like antibacterials and topical retinoids are supplemented with AHA peels and lotions. However, care should always be taken prior to commencing treatment with AHA peels and topical products. By obtaining a thorough history and physical examination, the physician will identify any specific factors like medications, prior procedures and medical conditions which can affect the outcome of the peel. During the interview, there should be open discussion of patient questions and concerns so that realistic expectations can be made. Pre- and post-peel regimens should also be reviewed in full as patient compliance is essential to ensure the success of a series of AHA peels.
Authors:
R C Tung; W F Bergfeld; A T Vidimos; B K Remzi
Related Documents :
12885265 - Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical ...
12793905 - Erythrocyte membrane fatty acid profile and saturation index in gallbladder carcinogene...
7701855 - Formic acid in the control of varroatosis: a practical approach.
3200265 - Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gal...
11835525 - Increased sialylation of polymeric lambda-iga1 in patients with iga nephropathy.
8163735 - Proton probe and acid etching for determining fluoride profiles in porous porcine enamel.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American journal of clinical dermatology     Volume:  1     ISSN:  1175-0561     ISO Abbreviation:  Am J Clin Dermatol     Publication Date:    2000 Mar-Apr
Date Detail:
Created Date:  2001-11-12     Completed Date:  2002-07-16     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  100895290     Medline TA:  Am J Clin Dermatol     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  81-8     Citation Subset:  IM    
Affiliation:
Cleveland Clinic Foundation, Department of Dermatology, Cleveland, Ohio, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acne Vulgaris / drug therapy
Chemexfoliation*
Clinical Protocols
Humans
Hydroxy Acids / pharmacology,  therapeutic use*
Keratosis / drug therapy
Rosacea / drug therapy
Skin Aging / drug effects
Skin Diseases / drug therapy*
Chemical
Reg. No./Substance:
0/Hydroxy Acids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management of seborrheic dermatitis and pityriasis versicolor.
Next Document:  Management of hirsutism.